1-4 of 4
Evert de Jonge
Close
Sort by
Journal Articles

Detecting measurable residual disease beyond 10 −4 by an IGHV leader-based NGS approach improves prognostic stratification in CLL

Paul J. Hengeveld, Michèle Y. van der Klift, P. Martijn Kolijn, Frédéric Davi, François G. Kavelaars, Evert de Jonge, Sandra Robrecht, Jorn L. J. C. Assmann, Lina van der Straten, Matthias Ritgen, Peter E. Westerweel, Kirsten Fischer, Valentin Goede, Michael Hallek, Mark-David Levin, Anton W. Langerak
Journal: Blood
Blood (2023) 141 (5): 519–528.
https://doi.org/10.1182/blood.2022017411
Published: 2023
Includes: Supplemental data
Journal Articles

Up-regulation of HIV coreceptors CXCR4 and CCR5 on CD4 + T cells during human endotoxemia and after stimulation with (myco)bacterial antigens: the role of cytokines

Nicole P. Juffermans, William A. Paxton, Pascale E. P. Dekkers, Annelies Verbon, Evert de Jonge, Peter Speelman, Sander J. H. van Deventer, Tom van der Poll
Journal: Blood
Blood (2000) 96 (8): 2649–2654.
https://doi.org/10.1182/blood.V96.8.2649
Published: 2000
Journal Articles

The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation

Rendrik F. Franco, Evert de Jonge, Pascale E. P. Dekkers, Janneke J. Timmerman, C. Arnold Spek, Sander J. H. van Deventer, Peter van Deursen, Liesbeth van Kerkhoff, Bob van Gemen, Hugo ten Cate, Tom van der Poll, Pieter H. Reitsma
Journal: Blood
Blood (2000) 96 (2): 554–559.
https://doi.org/10.1182/blood.V96.2.554
Published: 2000
Journal Articles

Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia

Evert de Jonge, Pascale E. P. Dekkers, Abla A. Creasey, C. Erik Hack, Susan K. Paulson, Aziz Karim, Jozef Kesecioglu, Marcel Levi, Sander J. H. van Deventer, Tom van der Poll
Journal: Blood
Blood (2000) 95 (4): 1124–1129.
https://doi.org/10.1182/blood.V95.4.1124.002k20_1124_1129
Published: 2000